Reporting on the clinical procedures that have now been developed from the initial research on using monoclonal antibodies to diagnose and treat breast cancer, the 21 papers also review promising research still in the pipeline. The various descriptions of breast epithelial antigens consider their mo

The convening of the 3rd International Workshop on Monoclonal Antibodies and Breast Cancer had the character of a self-search exercise. After almost a decade of research in the basic and applied aspects of the use of serological means to diagnose and possibly treat breast cancer several milestones have been reached. Among them a clear understanding of immunopathological use and limitations of monoclonal antibodies against breast epithelium, the complete development and clinical use of immunoassays for circulating breast epithelial antigens, the striking advances in the diagnostic use of...